Mirae Asset Global Investments Co., Ltd.
Position in CNTA — Centessa Pharmaceuticals plc
CIK 1569395
SEOUL, M5
Position in CNTA
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$0
+$0 QoQ
Shares Held
6,238
+33.1% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CNTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Mirae Asset Global Investments Co., Ltd. holds $279,047,947 across 206 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
210,209 | $104,417,115 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
93,632 | $58,383,296 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
61,531 | $18,522,675 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
33,420 | $17,944,868 | |
| 5 | ARGX |
Argenx SE
|
11,164 | $10,357,623 | |
| 6 | ONC |
BeOne Medicines Ltd.
|
33,808 | $9,634,265 | |
| 7 | RPRX |
Royalty Pharma plc
|
150,556 | $8,441,674 | |
| 8 | INCY |
Incyte Corp
|
63,812 | $7,233,728 |
All Filings in CNTA
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | — | 6,238 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | — | 4,688 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | — | 3,709 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | — | 3,689 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | — | 3,055 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | — | 2,972 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | — | 2,556 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | — | 1,730 | Shares | Sole | 2024-07-30 | |
| 2022-06-30 | — | 57,342 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||